Loading…

Kv1.3 channel as a promising therapeutic target for acquired aplastic anemia

Saved in:

Bibliographic Details
Published in:	Medical hypotheses 2008-01, Vol.70 (5), p.1072-1072
Main Authors:	Hu, Xiaojing, Xu, Conggao, Cong, Yaqin
Format:	Article
Language:	English
Subjects:	Anemia, Aplastic - drug therapy Arthritis, Rheumatoid - therapy Autoantigens - chemistry Autoimmune Diseases - immunology Calcium - metabolism Diabetes Mellitus, Type 1 - therapy Humans Internal Medicine Kv1.3 Potassium Channel - antagonists & inhibitors Kv1.3 Potassium Channel - genetics Kv1.3 Potassium Channel - metabolism Models, Biological Models, Theoretical Multiple Sclerosis - therapy Phenotype T-Lymphocytes - metabolism Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c409t-7b9027a367c830884172eee2f63485cb88afe80e34acd71fcb9f4c54e54f9fd23
cites	cdi_FETCH-LOGICAL-c409t-7b9027a367c830884172eee2f63485cb88afe80e34acd71fcb9f4c54e54f9fd23
container_end_page	1072
container_issue	5
container_start_page	1072
container_title	Medical hypotheses
container_volume	70
creator	Hu, Xiaojing Xu, Conggao Cong, Yaqin
description
doi_str_mv	10.1016/j.mehy.2007.11.005
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70420319</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0306987707006391</els_id><sourcerecordid>70420319</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-7b9027a367c830884172eee2f63485cb88afe80e34acd71fcb9f4c54e54f9fd23</originalsourceid><addsrcrecordid>eNp9kU-LFDEQxYMo7uzqF_AgOXnrtipJd9IggiyrKw54UM8hk67eydh_ZpPuhfn2ppkBwYOnOtR7j1e_YuwNQomA9ftDOdD-VAoAXSKWANUztsFKikJorZ-zDUioi8ZofcWuUzoAQKOkecmu0GBlhMAN2357wlJyv3fjSD13iTt-jNMQUhgf-Lyn6I60zMHz2cUHmnk3Re784xIitdwde5fWpRtpCO4Ve9G5PtHry7xhvz7f_by9L7bfv3y9_bQtvIJmLvSuAaGdrLU3EoxRqAURia6WylR-Z4zryABJ5XyrsfO7plO-UlSprulaIW_Yu3Nubvq4UJpt7uup73ONaUlWgxIgsclCcRb6OKUUqbPHGAYXTxbBrgztwa4M7crQItrMMJveXtKX3UDtX8sFWhZ8OAso3_gUKNrkA42e2gzFz7adwv_zP_5j930Yg3f9bzpROkxLHDM9izYJC_bH-sX1iaABatmg_AOWzZdE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70420319</pqid></control><display><type>article</type><title>Kv1.3 channel as a promising therapeutic target for acquired aplastic anemia</title><source>Elsevier</source><creator>Hu, Xiaojing ; Xu, Conggao ; Cong, Yaqin</creator><creatorcontrib>Hu, Xiaojing ; Xu, Conggao ; Cong, Yaqin</creatorcontrib><identifier>ISSN: 0306-9877</identifier><identifier>EISSN: 1532-2777</identifier><identifier>DOI: 10.1016/j.mehy.2007.11.005</identifier><identifier>PMID: 18158221</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Anemia, Aplastic - drug therapy ; Arthritis, Rheumatoid - therapy ; Autoantigens - chemistry ; Autoimmune Diseases - immunology ; Calcium - metabolism ; Diabetes Mellitus, Type 1 - therapy ; Humans ; Internal Medicine ; Kv1.3 Potassium Channel - antagonists & inhibitors ; Kv1.3 Potassium Channel - genetics ; Kv1.3 Potassium Channel - metabolism ; Models, Biological ; Models, Theoretical ; Multiple Sclerosis - therapy ; Phenotype ; T-Lymphocytes - metabolism ; Treatment Outcome</subject><ispartof>Medical hypotheses, 2008-01, Vol.70 (5), p.1072-1072</ispartof><rights>Elsevier Ltd</rights><rights>2007 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-7b9027a367c830884172eee2f63485cb88afe80e34acd71fcb9f4c54e54f9fd23</citedby><cites>FETCH-LOGICAL-c409t-7b9027a367c830884172eee2f63485cb88afe80e34acd71fcb9f4c54e54f9fd23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18158221$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hu, Xiaojing</creatorcontrib><creatorcontrib>Xu, Conggao</creatorcontrib><creatorcontrib>Cong, Yaqin</creatorcontrib><title>Kv1.3 channel as a promising therapeutic target for acquired aplastic anemia</title><title>Medical hypotheses</title><addtitle>Med Hypotheses</addtitle><subject>Anemia, Aplastic - drug therapy</subject><subject>Arthritis, Rheumatoid - therapy</subject><subject>Autoantigens - chemistry</subject><subject>Autoimmune Diseases - immunology</subject><subject>Calcium - metabolism</subject><subject>Diabetes Mellitus, Type 1 - therapy</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Kv1.3 Potassium Channel - antagonists & inhibitors</subject><subject>Kv1.3 Potassium Channel - genetics</subject><subject>Kv1.3 Potassium Channel - metabolism</subject><subject>Models, Biological</subject><subject>Models, Theoretical</subject><subject>Multiple Sclerosis - therapy</subject><subject>Phenotype</subject><subject>T-Lymphocytes - metabolism</subject><subject>Treatment Outcome</subject><issn>0306-9877</issn><issn>1532-2777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kU-LFDEQxYMo7uzqF_AgOXnrtipJd9IggiyrKw54UM8hk67eydh_ZpPuhfn2ppkBwYOnOtR7j1e_YuwNQomA9ftDOdD-VAoAXSKWANUztsFKikJorZ-zDUioi8ZofcWuUzoAQKOkecmu0GBlhMAN2357wlJyv3fjSD13iTt-jNMQUhgf-Lyn6I60zMHz2cUHmnk3Re784xIitdwde5fWpRtpCO4Ve9G5PtHry7xhvz7f_by9L7bfv3y9_bQtvIJmLvSuAaGdrLU3EoxRqAURia6WylR-Z4zryABJ5XyrsfO7plO-UlSprulaIW_Yu3Nubvq4UJpt7uup73ONaUlWgxIgsclCcRb6OKUUqbPHGAYXTxbBrgztwa4M7crQItrMMJveXtKX3UDtX8sFWhZ8OAso3_gUKNrkA42e2gzFz7adwv_zP_5j930Yg3f9bzpROkxLHDM9izYJC_bH-sX1iaABatmg_AOWzZdE</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Hu, Xiaojing</creator><creator>Xu, Conggao</creator><creator>Cong, Yaqin</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080101</creationdate><title>Kv1.3 channel as a promising therapeutic target for acquired aplastic anemia</title><author>Hu, Xiaojing ; Xu, Conggao ; Cong, Yaqin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-7b9027a367c830884172eee2f63485cb88afe80e34acd71fcb9f4c54e54f9fd23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Anemia, Aplastic - drug therapy</topic><topic>Arthritis, Rheumatoid - therapy</topic><topic>Autoantigens - chemistry</topic><topic>Autoimmune Diseases - immunology</topic><topic>Calcium - metabolism</topic><topic>Diabetes Mellitus, Type 1 - therapy</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Kv1.3 Potassium Channel - antagonists & inhibitors</topic><topic>Kv1.3 Potassium Channel - genetics</topic><topic>Kv1.3 Potassium Channel - metabolism</topic><topic>Models, Biological</topic><topic>Models, Theoretical</topic><topic>Multiple Sclerosis - therapy</topic><topic>Phenotype</topic><topic>T-Lymphocytes - metabolism</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hu, Xiaojing</creatorcontrib><creatorcontrib>Xu, Conggao</creatorcontrib><creatorcontrib>Cong, Yaqin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical hypotheses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hu, Xiaojing</au><au>Xu, Conggao</au><au>Cong, Yaqin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kv1.3 channel as a promising therapeutic target for acquired aplastic anemia</atitle><jtitle>Medical hypotheses</jtitle><addtitle>Med Hypotheses</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>70</volume><issue>5</issue><spage>1072</spage><epage>1072</epage><pages>1072-1072</pages><issn>0306-9877</issn><eissn>1532-2777</eissn><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>18158221</pmid><doi>10.1016/j.mehy.2007.11.005</doi><tpages>1</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0306-9877
ispartof	Medical hypotheses, 2008-01, Vol.70 (5), p.1072-1072
issn	0306-9877 1532-2777
language	eng
recordid	cdi_proquest_miscellaneous_70420319
source	Elsevier
subjects	Anemia, Aplastic - drug therapy Arthritis, Rheumatoid - therapy Autoantigens - chemistry Autoimmune Diseases - immunology Calcium - metabolism Diabetes Mellitus, Type 1 - therapy Humans Internal Medicine Kv1.3 Potassium Channel - antagonists & inhibitors Kv1.3 Potassium Channel - genetics Kv1.3 Potassium Channel - metabolism Models, Biological Models, Theoretical Multiple Sclerosis - therapy Phenotype T-Lymphocytes - metabolism Treatment Outcome
title	Kv1.3 channel as a promising therapeutic target for acquired aplastic anemia
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T05%3A49%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kv1.3%20channel%20as%20a%20promising%20therapeutic%20target%20for%20acquired%20aplastic%20anemia&rft.jtitle=Medical%20hypotheses&rft.au=Hu,%20Xiaojing&rft.date=2008-01-01&rft.volume=70&rft.issue=5&rft.spage=1072&rft.epage=1072&rft.pages=1072-1072&rft.issn=0306-9877&rft.eissn=1532-2777&rft_id=info:doi/10.1016/j.mehy.2007.11.005&rft_dat=%3Cproquest_cross%3E70420319%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c409t-7b9027a367c830884172eee2f63485cb88afe80e34acd71fcb9f4c54e54f9fd23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70420319&rft_id=info:pmid/18158221&rfr_iscdi=true